Overview
Daniel Shevrin, MD, a medical oncologist at Endeavor Health, combines advanced cancer knowledge with compassion and personalized care. He helps patients understand complex diagnoses and collaborates on treatment plans that balance effectiveness and quality of life. Dr. Shevrin is actively involved in prostate cancer research, leading a genomics study to guide more precise therapies for men with advanced disease. He sees each patient as a person first and believes empathy is as essential as evidence-based care.
Dr. Shevrin is rated as an Elite provider by MediFind in the treatment of Prostate Cancer. His top areas of expertise are Prostate Cancer, Familial Prostate Cancer, Hereditary Neuroblastoma, Non-Muscle Invasive Bladder Cancer, and Prostatectomy.
His clinical research consists of co-authoring 23 peer reviewed articles and participating in 4 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 22 articles and participated in 4 clinical trials in the study of Prostate Cancer.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- OTHER MEDICARE PART D
- PPO
- EPO
- HMO
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- EPO
- HMO
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- OTHER MANAGED MEDICAID
- OTHER MEDICAID
- STATE MEDICAID
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- EPO
- HMO
- PPO
- EPO
- HMO
- POS
- PPO
- MEDICARE DISCOUNT CARD
- MEDICARE PDP
- OTHER MEDICARE
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
- MEDICARE MAPD
- MEDICARE SNP
Locations
2650 Ridge Ave., Kellogg Cancer Center, Evanston, IL 60201
2180 Pfingsten Rd., Kellogg Cancer Center, Glenview, IL 60026
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
4 Clinical Trials
Edward Schaeffer is an Oncologist in Chicago, Illinois. Dr. Schaeffer has been practicing medicine for over 25 years and is rated as a Distinguished provider by MediFind in the treatment of Prostate Cancer. His top areas of expertise are Prostate Cancer, Familial Prostate Cancer, Bladder Cancer, Prostatectomy, and Ureteroscopy.
University Of Chicago
Russell Szmulewitz is a Hematologist Oncology specialist and a Hematologist in Chicago, Illinois. Dr. Szmulewitz is rated as a Distinguished provider by MediFind in the treatment of Prostate Cancer. His top areas of expertise are Prostate Cancer, Familial Prostate Cancer, Renal Cell Carcinoma (RCC), Prostatectomy, and Orchiectomy. Dr. Szmulewitz is currently accepting new patients.
David Vanderweele is a Hematologist and an Oncologist in Chicago, Illinois. Dr. Vanderweele has been practicing medicine for over 19 years and is rated as a Distinguished provider by MediFind in the treatment of Prostate Cancer. His top areas of expertise are Prostate Cancer, Familial Prostate Cancer, Muscle Invasive Bladder Cancer, Non-Muscle Invasive Bladder Cancer, and Prostatectomy.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Elite
- Familial Prostate CancerDr. Shevrin isElite. Learn about Familial Prostate Cancer.
- Prostate CancerDr. Shevrin isElite. Learn about Prostate Cancer.
- Distinguished
- Chromophobe Renal Cell CarcinomaDr. Shevrin isDistinguished. Learn about Chromophobe Renal Cell Carcinoma.
- Clear Cell SarcomaDr. Shevrin isDistinguished. Learn about Clear Cell Sarcoma.
- Familial Wilms Tumor 2Dr. Shevrin isDistinguished. Learn about Familial Wilms Tumor 2.
- Hereditary NeuroblastomaDr. Shevrin isDistinguished. Learn about Hereditary Neuroblastoma.
- Muscle Invasive Bladder CancerDr. Shevrin isDistinguished. Learn about Muscle Invasive Bladder Cancer.
- Non-Muscle Invasive Bladder CancerDr. Shevrin isDistinguished. Learn about Non-Muscle Invasive Bladder Cancer.
- Advanced
- Adrenal CancerDr. Shevrin isAdvanced. Learn about Adrenal Cancer.
- Adult Soft Tissue SarcomaDr. Shevrin isAdvanced. Learn about Adult Soft Tissue Sarcoma.
- Bladder CancerDr. Shevrin isAdvanced. Learn about Bladder Cancer.
- ChoriocarcinomaDr. Shevrin isAdvanced. Learn about Choriocarcinoma.
- NeuroblastomaDr. Shevrin isAdvanced. Learn about Neuroblastoma.
- Teratoma of the MediastinumDr. Shevrin isAdvanced. Learn about Teratoma of the Mediastinum.
- Experienced
- AgranulocytosisDr. Shevrin isExperienced. Learn about Agranulocytosis.
- ALK-Positive Non-Small Cell Lung CancerDr. Shevrin isExperienced. Learn about ALK-Positive Non-Small Cell Lung Cancer.
- Bone TumorDr. Shevrin isExperienced. Learn about Bone Tumor.
- Breast CancerDr. Shevrin isExperienced. Learn about Breast Cancer.
- ChondrosarcomaDr. Shevrin isExperienced. Learn about Chondrosarcoma.
- Chronic Familial NeutropeniaDr. Shevrin isExperienced. Learn about Chronic Familial Neutropenia.